Steward Partners Investment Advisory, LLC Blueprint Medicines Corp Transaction History
Steward Partners Investment Advisory, LLC
- $10.6 Billion
- Q3 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 3,351 shares of BPMC stock, worth $300,048. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,351
Previous 2,610
28.39%
Holding current value
$300,048
Previous $281,000
9.96%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding BPMC
# of Institutions
351Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$598 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$595 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$482 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$355 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$248 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.35B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...